The Petri dish is a shallow, circular, glass or plastic dish with a loose-fitting cover over the top and sides, used for culturing bacteria and other microorganisms. The story of the Petri dish is an interesting one. Julius Richard Petri (1852-1921), a bacteriologist, worked for the master of “germ theory” in Germany in the late 1800s, Robert Koch (1843-1910). Initially, bacteria were cultured in liquid broth–a practice captured in famous images of experiments on spontaneous generation. Koch saw the advantage of growing bacteria on a solid medium instead. By spreading out mixtures of microorganisms on a solid surface, he could separate individual types in isolated colonies. With pure colonies, he could investigate the effects of each bacterium. The method allowed Koch to identify the specific organisms that cause tuberculosis, cholera, diphtheria, among many other diseases–and then to develop vaccines. At first, however, Koch used a “puddle” of gelatin on a flat piece of glass. Later, the gelatin was spread on the side of a flat bottle, accessed through a narrow opening at the end. Petri, however, realized that one could pour the gelatin in a shallow dish, and put a cover on it, making it easier to get at the bacterial cultures. Since then, of course, the Petri dish has become a staple in laboratory work–and not just in studying microbes. Koch’s work is certainly remembered (though oddly his name does not carry beyond the world of microbiologists, in the way that Pasteur’s has). However, at the same time, the name of Koch’s assistant has become a household word, though few know exactly who he was.

SyntheMed, Inc., a biomaterials company engaged in the development and commercialization of anti-adhesion and drug delivery products, announced that the Circulatory System Devices Advisory Panel of the FDA has recommended approval of REPEL-CV® Adhesion Barrier for use in pediatric patients (21 and younger) who are likely to need secondary open heart surgery. The panel also recommended the development of additional safety data as a basis for expanding the indicated use to include adult patients.

Target Health is pleased that it provided clinical trial monitoring, biostatistics, data management, medical writing, and regulatory services for the program. Target Health also prepared and submitted the PMA, including the eCopy. Target e*CRF® was used for the pivotal trial.

For more information, please contact Dr. Jules T. Mitchel. or Joyce Hays.

A team of Brown University biomedical engineers has invented a 3-D Petri dish that can grow cells in three dimensions, a method that promises to quickly and cheaply produce more realistic cells for drug development and tissue transplantation.

Well-rounded growth. A new 3-D Petri dish allows cells to assemble themselves into bits of microtissue with natural cell-to-cell connections. (Credit: Peter Chai and Anthony Napolitano)

The technique employs a new dish – cleverly crafted from a sugary substance long used in science laboratories – that allows cells to self-assemble naturally and form “microtissues.” A description of how the 3-D dish works appears in the journal Tissue Engineering.

“It’s a new technology with a lot of promise to improve biomedical research,” said Jeffrey Morgan, a Brown professor of medical science and engineering.

Morgan conceived and created the 3-D Petri dish with a team of Brown students led by Anthony Napolitano, a Ph.D. candidate in the biomedical engineering program. Napolitano spent two years perfecting the new dish and recently won a $15,000 award from the National Collegiate Inventors and Innovators Alliance to develop the patent-pending technology into a commercially viable product.

“This technology is an inexpensive and easy-to-use alternative to current 3-D cell culture methods,” Napolitano said. “It’s the next generation.”

The technology tackles a topic of increasing interest to scientists: creating hothouse cells that look and behave more like cells grown in the human body. Since 1877, scientists have relied on the Petri dish to grow, or culture, cells. The cells stick to the bottom of the dishes and spread out as they multiply. In the body, however, cells don’t grow that way. They are surrounded by other cells in three dimensions, forming tissues such as skin, muscle, and bone. This is what happens in Morgan’s 3-D dish.

The clear, rubbery dish is the size of a silver dollar. It is made from a water-based gel made of agarose, a complex carbohydrate long used in molecular biology. This gel has a few benefits. It is porous, allowing nutrients and waste to circulate. And it is non-adhesive, so cells won’t stick to it. At the bottom of the dish sit 820 tiny recesses or wells. When cells are added to the dish –about 1 million at a time – roughly 1,000 sink to the bottom of each well and form a pile. These close quarters allow cells to self-assemble, or form natural cell-to-cell connections, a process not possible in traditional Petri dishes.

The result: microtissues consisting of hundreds of cells, even of different types. In Tissue Engineering, the Brown team describes how they combined human fibroblasts, which make connective tissue, and endothelial cells, which line the heart and blood vessels. The cells came together to form spheres and doughnut-shaped clusters. The process was quick – self-assembly took place in less than 24 hours.

“These microtissues have several potential uses,” Morgan said. “They can be used to test new cancer compounds and other drugs. And they can be transplanted into the body to regenerate tissue, such as pancreatic cells for diabetics. While there are other methods out there for making microtissues, our 3-D technology is fast, easy and inexpensive. It can make hundreds of thousands of microtissues in a single step.”

Differences in culture techniques matter in biomedicine, according to a growing body of research. Studies show sometimes dramatic differences in the shape, function and growth patterns of cells cultured in 2-D compared with cells cultured in 3-D. For example, a recent Brown study found that nerve cells grown in 3-D environments grew faster, had a more realistic shape and deployed hundreds of different genes compared to cells grown in 2-D environments.

That’s why several laboratories are pursuing 3-D cell culture methods. Brown Technology Partnerships has filed a patent application based on the technology developed in the Morgan lab and is actively pursuing licensing partners.

Napolitano was lead author of the Tissue Engineering article, and Morgan was senior author. Other members of the research team included Peter Chai, a student at The Warren Alpert Medical School of Brown University and Dylan Dean, an M.D./Ph.D. graduate student in the molecular pharmacology and physiology program.

The National Science Foundation funded the research.

Note: This story has been adapted from a news release issued by Brown University.